×
Nav 1: 19.3107
Date : 20-May-2025
Average AUM : 118.11
| Stock Name | Sector | Value Mn | % of Total Holdings | More Details |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | Pharmaceuticals | 217.9 | 13.65% | |
| Cipla | Pharmaceuticals | 107.5 | 6.74% | |
| Dr Reddys Laboratories | Pharmaceuticals | 103.4 | 6.48% | |
| Apollo Hospitals Enterprises | Hospital | 86.4 | 5.42% | |
| ELI LILLY ORD SHS | Foreign equity | 84.5 | 5.29% | |
| Max Healthcare Institute | Hospital | 82.9 | 5.19% | |
| Divis Laboratories | Pharmaceuticals | 74.6 | 4.67% | |
| Lupin | Pharmaceuticals | 63.4 | 3.97% | |
| Aurobindo Pharma | Pharmaceuticals | 51.5 | 3.23% | |
| Novo Nordisk A/S | Foreign equity | 48.7 | 3.05% | |
| Torrent Pharmaceuticals | Pharmaceuticals | 43.4 | 2.72% | |
| Johnson & Johnson | Foreign equity | 43 | 2.69% | |
| AbbVie Inc | Foreign equity | 37.6 | 2.36% | |
| Fortis Healthcare | Hospital | 34 | 2.13% | |
| Merck & Co Inc Shs | Foreign equity | 32.3 | 2.02% | |
| Mankind Pharma | Pharmaceuticals | 31.2 | 1.96% | |
| Glenmark Pharmaceuticals | Pharmaceuticals | 30.9 | 1.94% | |
| NOVARTIS AG | Foreign equity | 25.7 | 1.61% | |
| Thermo Fisher Scientific Inc | Foreign equity | 25.3 | 1.59% | |
| Ipca Laboratories | Pharmaceuticals | 24.7 | 1.55% | |
| Abbott Laboratories | Foreign equity | 21.3 | 1.33% | |
| Laurus Labs | Pharmaceuticals | 20.4 | 1.28% | |
| Danaher Corporation | Foreign equity | 20.3 | 1.27% | |
| Amgen | Foreign equity | 19.2 | 1.20% | |
| Syngene International | Healthcare research, analytics & technology | 19.1 | 1.20% | |
| Intuitive Surgical | Foreign equity | 18.8 | 1.18% | |
| Biocon | Pharmaceuticals | 18.7 | 1.17% | |
| Gland Pharma | Pharmaceuticals | 17.3 | 1.08% | |
| Jb Chemicals & Pharmaceuticals | Pharmaceuticals | 17.1 | 1.07% | |
| Ajanta Pharma | Pharmaceuticals | 16.9 | 1.06% | |
| DR LAL PATHLABS | Healthcare service provider | 16 | 1.00% | |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals | 15.1 | 0.95% | |
| Suven Pharmaceuticals | Pharmaceuticals | 13.7 | 0.86% | |
| Vertex Pharmaceuticals | Foreign equity | 13.7 | 0.86% | |
| Stryker Corporation | Foreign equity | 13.4 | 0.84% | |
| Medtronic Plc | Foreign equity | 12.6 | 0.79% | |
| Narayana Hrudayalaya | Hospital | 11.3 | 0.71% | |
| Global Health | Hospital | 11 | 0.69% | |
| Gilead Sciences | Foreign equity | 10.6 | 0.66% | |
| Pfizer | Pharmaceuticals | 10.3 | 0.64% | |
| Becton Dickinson and Co | Foreign equity | 7.5 | 0.47% | |
| Iqvia Holdings | Foreign equity | 4.9 | 0.31% | |
| Agilent Technologies Inc | Foreign equity | 4.5 | 0.28% | |
| Sanofi Consumer Healthcare India | Pharmaceuticals | 3.4 | 0.21% | |
| Moderna Inc | Foreign equity | 2.7 | 0.17% | |
| ILLUMINA | Foreign equity | 2.2 | 0.14% | |
| Sun Pharmaceutical Industries | Pharmaceuticals | 187.4 | 11.16% | |
| Cipla | Pharmaceuticals | 98 | 5.84% | |
| Dr Reddys Laboratories | Pharmaceuticals | 80.8 | 4.81% | |
| Apollo Hospitals Enterprises | Hospital | 89.3 | 5.32% | |
| ELI LILLY ORD SHS | Foreign equity | 96.5 | 5.75% | |
| Max Healthcare Institute | Hospital | 103.1 | 6.14% | |
| Divis Laboratories | Pharmaceuticals | 93 | 5.54% | |
| Lupin | Pharmaceuticals | 51.8 | 3.08% | |
| Aurobindo Pharma | Pharmaceuticals | 34.4 | 2.05% | |
| Novo Nordisk A/S | Foreign equity | 22 | 1.31% | |
| Torrent Pharmaceuticals | Pharmaceuticals | 48.7 | 2.90% | |
| Johnson & Johnson | Foreign equity | 63 | 3.75% | |
| AbbVie Inc | Foreign equity | 53.4 | 3.18% | |
| Fortis Healthcare | Hospital | 58 | 3.45% | |
| Merck & Co Inc Shs | Foreign equity | 29.9 | 1.78% | |
| Mankind Pharma | Pharmaceuticals | 34.1 | 2.03% | |
| Glenmark Pharmaceuticals | Pharmaceuticals | 30.8 | 1.84% | |
| NOVARTIS AG | Foreign equity | 32.6 | 1.94% | |
| Thermo Fisher Scientific Inc | Foreign equity | 29.8 | 1.77% | |
| Ipca Laboratories | Pharmaceuticals | 20.5 | 1.22% | |
| Abbott Laboratories | Foreign equity | 29.8 | 1.78% | |
| Laurus Labs | Pharmaceuticals | 38.6 | 2.30% | |
| Danaher Corporation | Foreign equity | 19.2 | 1.15% | |
| Amgen | Foreign equity | 22.3 | 1.33% | |
| Syngene International | Healthcare research, analytics & technology | 13.6 | 0.81% | |
| Intuitive Surgical | Foreign equity | 26.6 | 1.58% | |
| Biocon | Pharmaceuticals | 23 | 1.37% | |
| Gland Pharma | Pharmaceuticals | 16.5 | 0.98% | |
| Jb Chemicals & Pharmaceuticals | Pharmaceuticals | 13.6 | 0.00% | |
| Ajanta Pharma | Pharmaceuticals | 12.5 | 0.74% | |
| DR LAL PATHLABS | Healthcare service provider | 13.3 | 0.00% | |
| GlaxoSmithKline Pharmaceuticals | Pharmaceuticals | 12.8 | 0.76% | |
| Suven Pharmaceuticals | Pharmaceuticals | 10 | 0.59% | |
| Vertex Pharmaceuticals | Foreign equity | 15.2 | 0.90% | |
| Stryker Corporation | Foreign equity | 17 | 1.01% | |
| Medtronic Plc | Foreign equity | 16.1 | 0.96% | |
| Narayana Hrudayalaya | Hospital | 14.5 | 0.86% | |
| Global Health | Hospital | 12.2 | 0.73% | |
| Gilead Sciences | Foreign equity | 20.7 | 1.23% | |
| Pfizer | Pharmaceuticals | 8.6 | 0.00% | |
| Becton Dickinson and Co | Foreign equity | 7.1 | 0.42% | |
| Iqvia Holdings | Foreign equity | 5.2 | 0.31% | |
| Agilent Technologies Inc | Foreign equity | 5.8 | 0.34% | |
| Sanofi Consumer Healthcare India | Pharmaceuticals | 3.4 | 0.00% | |
| Moderna Inc | Foreign equity | 2.7 | 0.00% | |
| ILLUMINA | Foreign equity | 2.7 | 0.16% | |
| Zydus Lifesciences | Pharmaceuticals | 28.3 | 1.69% | |
| Regeneron Pharmaceuticals | Foreign equity | 9.7 | 0.58% | |
| GRAIL INC | Foreign equity | 0.1 | 0.00% | |
| Alkem Laboratories | Pharmaceuticals | 26.6 | 1.59% | |
| Piramal Pharma | Pharmaceuticals | 13.8 | 0.82% |